1921
Volume 100, Issue 6
  • ISSN: 0002-9637
  • E-ISSN: 1476-1645

Abstract

Abstract.

Vaginal self-sampling and human papillomavirus (HPV) DNA testing can be useful tools for women with limited access to health care living in sub-Saharan Africa. To assess the feasibility and acceptability of vaginal self-sampling and high-risk HPV prevalence in two villages of central Senegal, women were asked to self-sample vaginal swabs for HPV detection in May, 2016. Vaginal swabs were collected from 133 women and were tested for HPV genotyping. The acceptability rate of vaginal self-sampling was 98.5%, and 99.2% of the women (133/134) used the device correctly. The quality of self-sampling was satisfactory in 100% of the samples; 10.5% of the samples were positive for HPV, including 6% with high-risk HPV types and 4% with low-risk HPV types. This preliminary study indicates that vaginal self-sampling is a valuable strategy for high-risk HPV detection and cervical cancer screening in a population of women not attending gynecologic screening in rural areas of Senegal.

Loading

Article metrics loading...

The graphs shown below represent data from March 2017
/content/journals/10.4269/ajtmh.19-0045
2019-04-15
2020-06-05
Loading full text...

Full text loading...

/deliver/fulltext/14761645/100/6/tpmd190045.html?itemId=/content/journals/10.4269/ajtmh.19-0045&mimeType=html&fmt=ahah

References

  1. Louie KS, de Sanjose S, Mayaud P, 2009. Epidemiology and prevention of human papillomavirus and cervical cancer in sub-Saharan Africa: a comprehensive review. Trop Med Int Health 14: 12871302.
    [Google Scholar]
  2. Mbaye el HS, Gheit T, Dem A, McKay-Chopin S, Toure-Kane NC, Mboup S, Tommasino M, Sylla BS, Boye CS, 2014. Human papillomavirus infection in women in four regions of Senegal. J Med Virol 86: 248256.
    [Google Scholar]
  3. Smith JS, Lindsay L, Hoots B, Keys J, Franceschi S, Winer R, Clifford GM, 2007. Human papillomavirus type distribution in invasive cervical cancer and high-grade cervical lesions: a meta-analysis update. Int J Cancer 121: 621632.
    [Google Scholar]
  4. Sancho-Garnier H, Tamalet C, Halfon P, Leandri FX, Le Retraite L, Djoufelkit K, Heid P, Davies P, Piana L, 2013. HPV self-sampling or the Pap-smear: a randomized study among cervical screening nonattenders from lower socioeconomic groups in France. Int J Cancer 133: 26812687.
    [Google Scholar]
  5. Kunckler M, Schumacher F, Kenfack B, Catarino R, Viviano M, Tincho E, Tebeu PM, Temogne L, Vassilakos P, Petignat P, 2017. Cervical cancer screening in a low-resource setting: a pilot study on an HPV-based screen-and-treat approach. Cancer Med 6: 17521761.
    [Google Scholar]
  6. Trape JF et al., 1994. The Dielmo project: a longitudinal study of natural malaria infection and the mechanisms of protective immunity in a community living in a holoendemic area of Senegal. Am J Trop Med Hyg 51: 123137.
    [Google Scholar]
  7. Sokhna C, Mediannikov O, Fenollar F, Bassene H, Diatta G, Tall A, Trape JF, Drancourt M, Raoult D, 2013. Point-of-care laboratory of pathogen diagnosis in rural Senegal. PLoS Negl Trop Dis 7: e1999.
    [Google Scholar]
  8. Tamalet C, Richet H, Carcopino X, Henry M, Leretraite L, Heid P, Leandri FX, Sancho-Garnier H, Piana L, 2010. Testing for human papillomavirus and measurement of viral load of HPV 16 and 18 in self-collected vaginal swabs of women who do not undergo cervical cytological screening in southern France. J Med Virol 82: 14311437.
    [Google Scholar]
  9. de Villiers EM, Fauquet C, Broker TR, Bernard HU, zur Hausen H, 2004. Classification of papillomaviruses. Virology 324: 1727.
    [Google Scholar]
  10. Carcopino X, Henry M, Benmoura D, Fallabregues AS, Richet H, Boubli L, Tamalet C, 2006. Determination of HPV type 16 and 18 viral load in cervical smears of women referred to colposcopy. J Med Virol 78: 11311140.
    [Google Scholar]
  11. Bouvard V et al., WHO International Agency for Research on Cancer Monograph Working Group, 2009. A review of human carcinogens—Part B: biological agents. Lancet Oncol 10: 321322.
    [Google Scholar]
  12. Lagier JC, Diagne N, Fenollar F, Tamalet C, Sokhna C, Raoult D, 2017. Vaginal self-sampling as a diagnosis tool in low-income countries and potential applications for exploring the infectious causes of miscarriage. Future Microbiol 12: 609620.
    [Google Scholar]
  13. Jones HE et al., 2007. Home-based versus clinic-based self-sampling and testing for sexually transmitted infections in Gugulethu, South Africa: randomised controlled trial. Sex Transm Infect 83: 552557.
    [Google Scholar]
  14. Bruni L et al., 2014. Human Papillomavirus and Related Diseases in the World, Summary Report. X. ICO Information Centre on HPV and Cancer (HPV Information Centre), 1218. Available at: https://www.sexrightsafrica.net/wp-content/uploads/2016/04/ICO-World-HPV-report-2015.pdf. Accessed April 11, 2019.
    [Google Scholar]
  15. Cubie HA et al., 2017. HPV prevalence in women attending cervical screening in rural Malawi using the cartridge-based Xpert(R) HPV assay. J Clin Virol 87: 14.
    [Google Scholar]
  16. Catarino R, Vassilakos P, Jinoro J, Broquet C, Benski AC, Meyer-Hamme U, Petignat P, 2016. Human papillomavirus prevalence and type-specific distribution of high- and low-risk genotypes among Malagasy women living in urban and rural areas. Cancer Epidemiol 42: 159166.
    [Google Scholar]
  17. Gultekin M, Akgul B, 2017. HPV screening in Islamic countries. Lancet Infect Dis 17: 368.
    [Google Scholar]
  18. Guan P, Howell-Jones R, Li N, Bruni L, de Sanjose S, Franceschi S, Clifford GM, 2012. Human papillomavirus types in 115,789 HPV-positive women: a meta-analysis from cervical infection to cancer. Int J Cancer 131: 23492359.
    [Google Scholar]
  19. Xi LF, Toure P, Critchlow CW, Hawes SE, Dembele B, Sow PS, Kiviat NB, 2003. Prevalence of specific types of human papillomavirus and cervical squamous intraepithelial lesions in consecutive, previously unscreened, West-African women over 35 years of age. Int J Cancer 103: 803809.
    [Google Scholar]
  20. De Vuyst H, Clifford G, Li N, Franceschi S, 2009. HPV infection in Europe. Eur J Cancer 45: 26322639.
    [Google Scholar]
  21. Nilyanimit P, Chansaenroj J, Poomipak W, Praianantathavorn K, Payungporn S, Poovorawan Y, 2018. Comparison of four human papillomavirus genotyping methods: next-generation sequencing, INNO-LiPA, electrochemical DNA chip, and nested-PCR. Ann Lab Med 38: 139146.
    [Google Scholar]
  22. Mayrand MH et al., 2007. Human papillomavirus DNA versus Papanicolaou screening test for cervical cancer. N Engl J Med 357: 15791588.
    [Google Scholar]
  23. Toliman P et al., 2016. Field evaluation of Xpert HPV point-of-care test for detection of human papillomavirus infection by use of self-collected vaginal and clinician-collected cervical specimens. J Clin Microbiol 54: 17341737.
    [Google Scholar]
  24. Cuzick J et al., 2015. Performance of the Xpert HPV assay in women attending for cervical screening. Papillomavirus Res 1: 3237.
    [Google Scholar]
http://instance.metastore.ingenta.com/content/journals/10.4269/ajtmh.19-0045
Loading
/content/journals/10.4269/ajtmh.19-0045
Loading

Data & Media loading...

  • Received : 14 Jan 2019
  • Accepted : 21 Mar 2019
  • Published online : 15 Apr 2019
This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error